Genespire
  • About us
    • The company
    • Management Team
    • Board of Directors
    • Founders
    • Investors
  • Our science
    • Overview
    • Programs
  • News and Events
    • News
  • Contact
  • IT
  • EN
Select Page

News

Genespire Strengthens Management Team with Two Key Appointments

May 5, 2021

read more

Genespire appoints Jörn Aldag as Chairman of the Board of Directors

Jul 2, 2020

read more

Genespire and the San Raffaele Telethon Institute for Gene Therapy announce publication in Nature Biotechnology on enhanced gene editing technique in hematopoietic stem cells

Jun 2, 2020

read more

Genespire and SR-Tiget announce strategic alliance for the development of transformative gene therapies for genetic diseases and disclose collaboration focus

May 13, 2020

read more

Genespire Secures €16 Million Series A Financing from Sofinnova Partners to Advance Transformative Gene Therapies

Apr 1, 2020

read more
Next Entries »

Genespire Srl

Genespire’s mission is to enable children affected by genetic diseases to benefit from the life-changing potential of gene therapy.

Legal Address

Via Visconti di Modrone, 18
20122 Milano
Italy

e-mail: info@genespire.com

Useful links

  • Privacy Policy
  • Cookie Policy
  • Credits

This site uses only technical cookies and does not perform any profiling or collection of personal data through cookies. Simply browsing the site does not require the user’s consent.
© GENESPIRE Srl. All rights reserved. VAT: 11231080968